Bangladesh now has a total of 186,029 doses of Covishield vaccine in stock after administering some 10,013,971 doses since the start of the coronavirus vaccination program in the country.
The Department of Health unveiled the information in a press release on Wednesday.
Till now, Bangladesh has received 10,200,000 Covishield doses from India's Serum Institute of India.
According to the press release, out of the 10,013,971 doses used, 5,820,015 people took the first dose and 4,193,956 people took the second dose.
Of those who received the first dose of the vaccine, 3,609,065 were men and 2,210,950 were women.
Meanwhile, 2,680,378 males and 1,513,578 females received the the second dose.
According to the Department of Health, 7,248,629 people have registered for vaccination in the country till 5:30pm on Wednesday.
The coronavirus vaccination program started on February 7 in Bangladesh. The activity runs every day from 8:30am to 2:30pm. Meanwhile, the second dose vaccination program started on April 8.
The Covishield vaccine developed by the Serum Institute of India, invented by Oxford AstraZeneca, is currently being administered in the country.
The government signed an agreement to receive 30 million doses of Covishield from Serum Institute.
Every month, Bangladesh was supposed to receive 5 million doses but so far, only 10,200,000 doses have been received.
However, on Tuesday, Bangladesh received the first consignment of 100,620 doses of the Pfizer-BioNTech Covid-19 vaccine. The health authorities in Bangladesh would need more seven to 10 days to start administrating the Pfizer Covid-19 vaccine.
Meanwhile, China handed over 500,000 doses of the Sinopharm vaccine to Bangladesh as a special gift on May 12. Beijing has said that it will send another 600,000 doses of the vaccine to Dhaka.
Bangladesh is also negotiating with Russia to get their Sputnik V vaccine.